North America Antibiotics Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors); and Country
Market Introduction
Antibiotic is a group of medicines that fights bacterial infections, and sometimes protozoan diseases. Moreover, they are used to treat many diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, eye & ear infections, and others. Antibiotics are also called antimicrobial or antibacterial. After the discovery of the antibiotic penicillin in 1920, various other antibiotic compounds have been used to treat several bacterial infections.
Get more information on this report : 
Market Overview and Dynamics
The North America antibiotics market is expected to reach US$ 18,004.25 million by 2027 from US$ 13,527.79 million in 2019. The market is estimated to grow with a CAGR of 3.9% from 2020 to 2027. Factors driving the market growth areprevalence of infectious diseases andincreasing development of generic drugs. However, the tedious and expensive process of antibiotic development and the impact of COVID-19 pandemic are likely to have a negative impact on market growth.
Key Market Segments
By drug class, the cephalosporins segment accounted for the largest market share in the North Americaantibiotics market in 2019. In terms of action mechanism, cell wall synthesis inhibitors segment is expected to hold the largest market share of the antibioticsmarket by 2027.
Major Sources and Companies Listed
Some of the major primary and secondary sources forAntibioticsmarket included in the report are, World Health Organization (WHO), Food and Drug Administration (FDA), American Society for Microbiology (ASM), Centers for Disease Control and Prevention (CDC), Center for Disease Dynamics, Economics & Policy (CDDEP), and others.
Reasons to buy the report
- To understand the antibiotics market landscape and identifymarket segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for antibiotics market
- Efficiently plan M&A and partnership dealsin antibiotics market by identifying market segments with the most promising probable sales
- Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form antibiotics market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region.
NORTH AMERICAANTIBIOTICSMARKET SEGMENTATION
By Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
By Geography
- North America
- US
- Canada
- Mexico
Company Profiles
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Antibiotics Market – By Drug Class
1.3.2 North America Antibiotics Market – By Action Mechanism
1.3.3 North America Antibiotics Market – By Country
2. North America Antibiotics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Antibiotics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Antibiotics Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Antibiotics Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Bacterial Infections
5.1.2 Increasing Development of Generic Drugs
5.2 Key Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Growing Investments to Combat Antimicrobial Resistance
5.4 Future Trends
5.4.1 Incorporation of Novel Computing Technologies for Antibiotics Discovery
5.5 Impact analysis
6. Antibiotics Market – North America Analysis
6.1 North America Antibiotics Market Revenue Forecasts and Analysis
7. North America Antibiotics Market Analysis And Forecasts To 2027 – By Drug Class
7.1 Overview
7.2 North America Antibiotics market, By Drug Class 2019 & 2027 (%)
7.2.1 North America Antibiotics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)
7.3 Sulfonamides
7.3.1 Overview
7.3.2 North America Sulfonamides Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Aminoglycosides
7.4.1 Overview
7.4.2 North America Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Carbapenem
7.5.1 Overview
7.5.2 North America Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Macrolides
7.6.1 Overview
7.6.2 North America Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Fluoroquinolones
7.7.1 Overview
7.7.2 North America Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Penicillin
7.8.1 Overview
7.8.2 North America Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
7.9 Cephalosporins
7.9.1 Overview
7.9.2 North America Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
7.10 Others
7.10.1 Overview
7.10.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Antibiotics Market Analysis – By Action Mechanism
8.1 Overview
8.2 North America Antibiotics Market, By Action Mechanism 2019-2027 (%)
8.2.1 North America Antibiotics Market Revenue and Forecasts to 2027, By Action Mechanism (US$ Mn)
8.3 Mycolic Acid Inhibitors
8.3.1 Overview
8.3.2 North America Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 RNA Synthesis Inhibitors
8.4.1 Overview
8.4.2 North America RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 DNA Synthesis Inhibitors
8.5.1 Overview
8.5.2 North America DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Protein Synthesis Inhibitors
8.6.1 Overview
8.6.2 North America Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Cell Wall Synthesis Inhibitors
8.7.1 Overview
8.7.2 North America Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Antibiotics Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 North America Antibiotics Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 North America: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.4 North America: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.5 North America: Antibiotics Market, by Country, 2019 & 2027 (%)
9.1.6 US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.6.3 US: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.7 Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.7.3 Canada: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.8 Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.8.3 Mexico: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on North America Antibiotics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Pfizer Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Johnson & Johnson Services, Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Eli Lilly and Company.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Abbott
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Word Index
LIST OF TABLES
Table 1. North America Antibiotics Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)
Table 2. North America Antibiotics Market Revenue and Forecasts To 2027, By Action Mechanism (US$ Mn)
Table 3. North America Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 5. US Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 6. US Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 9. Mexico Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 11. List of Abbreviation
LIST OF FIGURES
Figure 1. Antibiotics Market Segmentation
Figure 2. North America Antibiotics Market Overview
Figure 3. Cephalosporin Segment Held Largest Share of Product in Antibiotics Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Antibiotics Market - Leading Country Markets (US$ Mn)
Figure 6. Antibiotics Market - North America PEST Analysis
Figure 7. Antibiotics market impact analysis of driver and restraints
Figure 8. North America Antibiotics market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Antibiotics market, By Drug Class 2019 & 2027 (%)
Figure 10. North America Sulfonamides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Antibiotics Market, by Action Mechanism 2019 & 2027 (%)
Figure 19. North America Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. North America Antibiotics Market Revenue and Forecast to 2027 (USD Million)
Figure 27. North America: Antibiotics Market, by Country, 2019 & 2027 (%)
Figure 28. US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of Covid-19 Pandemic In North American Country Markets
The List of Companies - North America Antibiotics Market
- Johnson & Johnson Services, Inc
- Bristol-Myers Squibb Company
- Eli Lilly and Company.
- Abbott
- Pfizer Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Antibiotics Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.